SUBSCRIBE
SUBSCRIBE

Parexel International

NEWS
Business
Roivant Sciences Raises $200 Million, Bringing Its Valuation to $7 Billion
Vivek Ramaswamy’s Roivant Sciences, the umbrella company to 14 Vant companies, including Datavant, Enzyvant Sciences, Urovant Sciences and others, raised another $200 million in equity financing.
November 13, 2018
 · 
3 min read
 · 
Mark Terry
Drug Development
Biotech Manufacturing is Booming with Growth of Biologics and Gene Therapies
Biotech manufacturing is the non-glamorous side of biopharma, although its impact on the economy shouldn’t be underestimated. Here’s everything you need to know.
July 2, 2018
 · 
5 min read
 · 
Mark Terry
Business
Parexel International Taps New CEO Jamie Macdonald
After 35 years at the helm of Parexel International Corporation, co-founder Josef von Rickenbach is stepping down from his role as chief executive officer.
March 6, 2018
 · 
2 min read
 · 
Alex Keown
PAREXEL Sold to Investment Firm in $5 Billion Deal
Deals
PAREXEL Sold to Investment Firm in $5 Billion Deal
June 20, 2017
 · 
3 min read
PAREXEL Sold to Investment Firm in $5 Billion Deal
Job Trends
PAREXEL to Slash Up to 1,200 Jobs Worldwide
May 10, 2017
 · 
3 min read
PAREXEL Sold to Investment Firm in $5 Billion Deal
Deals
CRO Giant PAREXEL Explores $4 Billion Sale, Stock Jumps
May 9, 2017
 · 
3 min read
Business
PAREXEL Announces Date Of First Quarter Fiscal Year 2017 Earnings Release And Conference Call
October 13, 2016
 · 
1 min read
PAREXEL Sold to Investment Firm in $5 Billion Deal
Policy
PAREXEL Loses $160 Million in Value in One Day After Disclosing Possible ‘Misappropriation of Corporate Funds’
September 1, 2016
 · 
2 min read
Job Trends
PAREXEL International Stays Mum as 200 Ex-GlaxoSmithKline Workers are Reportedly Being Laid Off Today
July 30, 2015
 · 
2 min read
Load More
JOBS
IN THE PRESS
Business
Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China
September 27, 2022
 · 
3 min read
Business
Parexel Appoints Peyton Howell Chief Operating and Growth Officer; Promotes FDA Veteran Amy McKee, MD, to Chief Medical Officer and Global Head, Oncology Center of Excellence
September 14, 2022
 · 
4 min read
Business
Parexel Expands Network of Global Regulatory Experts
September 8, 2022
 · 
4 min read
Business
Parexel Bolsters Regulatory and Access Offering with Key Appointment
January 11, 2022
 · 
3 min read
Bio NC
EQT Private Equity and Goldman Sachs Asset Management Complete Acquisition of Parexel
November 15, 2021
 · 
6 min read
Business
Parexel Strengthens Clinical Data and Digital Services Offering with Key Appointment
October 4, 2021
 · 
3 min read
Business
Parexel’s Peyton Howell and Sofia Baig Named to 2021 PharmaVOICE 100
August 2, 2021
 · 
3 min read
Deals
EQT Private Equity and Goldman Sachs Asset Management to acquire Parexel, a leading global clinical research organization, for USD 8.5 billion
July 2, 2021
 · 
5 min read
Deals
Parexel to be Acquired by EQT Private Equity and Goldman Sachs Asset Management
July 2, 2021
 · 
6 min read
Drug Development
Parexel Recognized as Most Favored Provider in ISR CRO Phase I Quality Benchmarking Report
May 13, 2021
 · 
1 min read
Load More